Cellmax lancar produk urus luka lanjutan proprietari

The Malaysian government has launched a proprietary wound healing product, Cellmax, at the World Union of Wound Healing Societies 2026 Congress in Kuala Lumpur. Minister of Science, Technology and Innovation Chang Lih Kang, along with Cellmax chairman Loke Mei Chan, unveiled two main products: CellmaxTM freeze-dried powder and CellmaxTM wound spray.

These products, developed through eight years of research and investment of RM7 million, underwent clinical trials in collaboration with Hospital Kuala Lumpur to treat complex, chronic, and hard-to-heal wounds. The products adhere to safety standards and were registered with the Medical Devices Authority (MDA). Complex and chronic wounds can impose significant financial burdens on patients and the healthcare system.

Cellmax aims to improve wound healing and increase treatment efficacy, according to Loke. The proprietary formula has therapeutic potential in managing various dermatological conditions, reducing long-term treatment costs for patients recovering from chronic ulcers, traumatic injuries, and surgical wounds. Cellmax is exploring the development of mobile wound care devices to expand services beyond conventional healthcare facilities.

This initiative can help bring wound care services closer to patients, particularly in rural communities with limited access to healthcare. The initiative aims to expand local clinical treatment coverage and reduce hospital admissions.